Skip to main navigation Skip to search Skip to main content

Cytomegalovirus Colitis After 5‐Fluorouracil and Interferon‐α Therapy

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

Cytomegalovirus (CMV) infection is an opportunistic viral infection primarily affecting immunocompromised patients. Patients with inflammatory bowel disease have an increased risk for developing CMV infections of the gastrointestinal tract. While receiving continuous infusion of 5‐fluorouracil and interferon‐α, a 72‐year‐old woman with stage IV pancreatic carcinoma developed severe colitis with diarrhea that was refractory to conventional antidiarrheals. A biopsy specimen from the colon revealed CMV inclusions, which were confirmed by immunofluorescence. The patient was given ganciclovir 210 mg (5 mg/kg) every 12 hours for 14 days, and the diarrhea resolved after approximately 8 days of therapy. This is the first reported case of CMV colitis associated with combination 5‐fluorouracil and interferon‐α therapy. 1994 Pharmacotherapy Publications Inc.

Original languageEnglish
Pages (from-to)246-249
Number of pages4
JournalPharmacotherapy
Volume14
Issue number2
DOIs
StatePublished - 1994

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Cytomegalovirus Colitis After 5‐Fluorouracil and Interferon‐α Therapy'. Together they form a unique fingerprint.

Cite this